OpenAI announced a new series of AI models built to help life sciences researchers work faster. Why it matters: Biology ...

ACTO, uniting human intelligence with empathetic AI in Life Sciences, today announced the launch of SuperAgents, an industry-first AI innovation designed to orchestrate work for Life Sciences customer ...

Future Fields CEO Matt Anderson-Baron shares the raw lessons and hard pivots behind building a biotech company during Life Sciences Week in Edmonton. Matt Anderson-Baron is the CEO of Future Fields. - ...

OpenAI has officially entered the field of AI-assisted drug discovery, challenging competitors such as Google and triggering sharp declines in the stock prices of related publicly traded companies.

Marc Cummings, president and CEO of Life Science Washington, speaking at a one-day forum focused on AI-driven biotech that was held in Seattle in October 2025. (Life Science Washington Photo) Seattle ...

Experts say the emerging tech can dramatically accelerate advances in drug discovery, diagnostics and precision medicine. Quantum technology is synonymous with speed. It promises computers that can ...

In the rapidly advancing life science fields, endpoint polymerase chain reaction (PCR), real-time PCR (qPCR), and digital PCR (dPCR) have become indispensable tools that complement one another across ...

Suggested Citation: "1 Introduction." National Research Council. 2014. Convergence: Facilitating Transdisciplinary Integration of Life Sciences, Physical Sciences ...